Showing results (451-460 of 734) with videos related to

Sort By:
Pageof 74
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 13, 2014
Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphomaXiaoming Xing, Thomas J Flotte, Mark E Law, et al.
Leukemia|May 21, 2010
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphomaL F Porrata, K Rsitow, D J Inwards, et al.
Leukemia|May 25, 2011
The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphomaR A Wilcox, K Ristow, T M Habermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2014
Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphomaJacob P Smeltzer, Jason M Jones, Steven C Ziesmer, et al.
Cytokine|September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control studyBridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2016
Immunologic Autograft Engineering and Survival in Non-Hodgkin LymphomaLuis F Porrata, Edwin A Burgstaler, Jeffrey L Winters, et al.
Leukemia|December 8, 2010
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphomaT E Witzig, C B Reeder, B R LaPlant, et al.
Leukemia & Lymphoma|November 22, 2011
The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphomaRyan A Wilcox, Kay Ristow, Thomas M Habermann, et al.
Leukemia & Lymphoma|February 20, 2014
Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphomaLuis F Porrata, Kay M Ristow, Thomas M Habermann, et al.
Journal of Hematology & Oncology|June 13, 2014
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factorsSven de Vos, Andres Forero-Torres, Stephen M Ansell, et al.
Pageof 74